Siyuan Weng
- Cancer Research top 5%
- Cancer Genomics and Diagnostics 11
- Cancer-related molecular mechanisms research 10
- MicroRNA in disease regulation 6
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers 14
-
- Ferroptosis and cancer prognosis 18
- Immunology top 10%
- Immune cells in cancer 8
- Immunotherapy and Immune Responses 7
- Molecular Biology top 10%
- RNA modifications and cancer 8
- Journals
- Frontiers in Immunology (7 papers)Molecular Cancer (5 papers)Cellular Signalling (4 papers)
- Partner nations
- ChinaUnited KingdomUnited States
In The Last Decade
Siyuan Weng
72 papers receiving 1.5k citations
Hit Papers
Peers
Comparison fields: 5 of 98
- Cancer Research 442
- Oncology 523
- Pulmonary and Respiratory Medicine 530
- Immunology 314
- Molecular Biology 717
Countries citing papers authored by Siyuan Weng
This map shows the geographic impact of Siyuan Weng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Siyuan Weng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Siyuan Weng more than expected).
Fields of papers citing papers by Siyuan Weng
This network shows the impact of papers produced by Siyuan Weng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Siyuan Weng. The network helps show where Siyuan Weng may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Siyuan Weng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 4 | |
| 2 | 2025 | 5 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 5 | |
| 5 | 2025 | 5 | |
| 6 | 2025 | 3 | |
| 7 | 2024 | 7 | |
| 8 | 2024 | 5 | |
| 9 | 2024 | 15 | |
| 10 | 2024 | 10 | |
| 11 | 2024 | 13 | |
| 12 | 2024 | 1 | |
| 13 | 2023 | 3 | |
| 14 | 2023 | 2 | |
| 15 | 2023 | 1 | |
| 16 | 2023 | 8 | |
| 17 | 2023 | 50 | |
| 18 | 2022 | 21 | |
| 19 | 2022 | 61 | |
| 20 | 2022 | 13 |
About Siyuan Weng
Siyuan Weng is a scholar working on Cancer Research, Oncology and Pulmonary and Respiratory Medicine, having authored 75 papers that have together received 1.5k indexed citations. Recurring topics across this work include Ferroptosis and cancer prognosis (18 papers), Cancer Immunotherapy and Biomarkers (14 papers), Cancer Genomics and Diagnostics (11 papers), Cancer-related molecular mechanisms research (10 papers), RNA modifications and cancer (8 papers), Immune cells in cancer (8 papers), Immunotherapy and Immune Responses (7 papers) and MicroRNA in disease regulation (6 papers). The work is most often cited by research in Cancer Research (442 citations), Oncology (523 citations) and Pulmonary and Respiratory Medicine (530 citations). Siyuan Weng has collaborated with scholars based in China, United Kingdom and United States. Frequent co-authors include Xinwei Han, Zaoqu Liu, Hui Xu, Yuyuan Zhang, Long Liu, Chunguang Guo, Libo Wang, Qin Dang, Yuqing Ren and Taoyuan Lu. Their work appears in journals such as Frontiers in Immunology, Molecular Cancer, Cellular Signalling, Genes & Diseases and International Journal of Biological Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.